238 related articles for article (PubMed ID: 11809901)
1. Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography.
Deng D; Deng G; Smith MF; Zhou J; Xin H; Powell SM; Lu Y
Nucleic Acids Res; 2002 Feb; 30(3):E13. PubMed ID: 11809901
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the methylation in CpG island by denaturing high-performance liquid chromatography].
Deng D; Deng G; Lü Y
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):158-61. PubMed ID: 11798868
[TBL] [Abstract][Full Text] [Related]
3. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas.
Deng DJ; Zhou J; Zhu BD; Ji JF; Harper JC; Powell SM
World J Gastroenterol; 2003 Jan; 9(1):26-9. PubMed ID: 12508345
[TBL] [Abstract][Full Text] [Related]
4. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
Kang GH; Lee S; Shim YH; Kim JC; Ro JY
Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445
[TBL] [Abstract][Full Text] [Related]
5. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas.
Carvalho B; Pinto M; Cirnes L; Oliveira C; Machado JC; Suriano G; Hamelin R; Carneiro F; Seruca R
Eur J Cancer; 2003 Jun; 39(9):1222-7. PubMed ID: 12763209
[TBL] [Abstract][Full Text] [Related]
6. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
7. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2.
Holinski-Feder E; Müller-Koch Y; Friedl W; Moeslein G; Keller G; Plaschke J; Ballhausen W; Gross M; Baldwin-Jedele K; Jungck M; Mangold E; Vogelsang H; Schackert HK; Lohsea P; Murken J; Meitinger T
J Biochem Biophys Methods; 2001 Jan; 47(1-2):21-32. PubMed ID: 11179758
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
Oue N; Sentani K; Yokozaki H; Kitadai Y; Ito R; Yasui W
Pathobiology; 2001; 69(3):143-9. PubMed ID: 11872960
[TBL] [Abstract][Full Text] [Related]
9. [Quantification of cyclooxygenase-2 methylation in gastric mucosa by denaturing high performance liquid chromatography assay].
Nie XR; Zhang Y; Pan KF; Li WQ; You WC; Zhang L
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Jan; 44(1):54-7. PubMed ID: 20388365
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
Kang YH; Bae SI; Kim WH
J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
[TBL] [Abstract][Full Text] [Related]
12. [Quantification of methylation of SNCG CpG islands in human tissue samples by the combined COBRA-DHPLC assay].
Zhou J; Wen XZ; Deng DJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():20-4. PubMed ID: 17767852
[TBL] [Abstract][Full Text] [Related]
13. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer.
Betz B; Florl AR; Seifert HH; Dall P; Schulz WA; Niederacher D
Hum Mutat; 2004 Jun; 23(6):612-20. PubMed ID: 15146466
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of metallothionein-3 CpG island in gastric carcinoma.
Deng D; El-Rifai W; Ji J; Zhu B; Trampont P; Li J; Smith MF; Powel SM
Carcinogenesis; 2003 Jan; 24(1):25-9. PubMed ID: 12538345
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
[TBL] [Abstract][Full Text] [Related]
16. CpG island methylation in premalignant stages of gastric carcinoma.
Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
[TBL] [Abstract][Full Text] [Related]
17. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
[TBL] [Abstract][Full Text] [Related]
18. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Löf-Ohlin ZM; Nilsson TK
Oncol Rep; 2009 Mar; 21(3):721-9. PubMed ID: 19212632
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
Song SH; Jong HS; Choi HH; Inoue H; Tanabe T; Kim NK; Bang YJ
Cancer Res; 2001 Jun; 61(11):4628-35. PubMed ID: 11389100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
